MENAT Platelet Rich Plasma (PRP) Tubes Market to Grow at a CAGR of 16.6% to reach US$ 79.71 million from 2022 to 2028

The MENAT platelet rich plasma (PRP) tubes market is expected to grow from US$ 27.26 million in 2021 to US$ 79.71 million by 2028; it is estimated to grow at a CAGR of 16.6% from 2022 to 2028.

Platelet rich plasma tubes are vacuum sealed tubes that hold blood samples for platelet recovery. These tubes can also hold gel, buffy coat layer, or sodium citrate solution, which helps in the separation of platelet rich plasma and prevents blood clotting. The MENAT platelet rich plasma (PRP) tubes market growth is majorly driven by rising cosmetic and aesthetic procedures and increasing cases of sports injuries. 

Market Insights

Incorporation of Platelet-Rich Plasma in Regenerative Medicine

Regenerative medicine is a major part of the rapidly emerging biomedical research involving the development of new therapeutic strategies, resulting in significant advancements in the medical field. The rising cases of people suffering from peripheral nerve injury (PNI) have become common across MENAT, and the slow regeneration process of PNI leads to loss of nerve functions. In addition, research on the mechanism of peripheral nerve regeneration has accelerated significantly, and scholars are seeking different methods to enhance peripheral nerve regeneration. One such example is PRP therapy. PRP therapy incorporates mainstream technologies for repairing and rejuvenating the damaged tissue caused due to injury or chronic diseases. In the past few years, the usage of PRP injections as a therapeutic tool has significantly improved in regenerative medicine for wound healing and skin regeneration, cosmetic and plastic surgery, and orthopedic procedures. PRP comprises a platelet concentrate, which acts as a bioactive substance extracted from the autologous blood through the centrifugation process. A high concentration of platelets can release various growth factors after activation that can promote the proliferation and differentiation of tissue cells, accelerating the process of tissue regeneration; it is also widely used for hair regrowth. PRP therapy has also been utilized for musculoskeletal regeneration to heal sports-related injuries and orthopedic-associated injuries. PRP-based treatments have proved to be beneficial in healing acute hamstring-associated injuries, as per the National Institute of Health (NIH) report.

Thus, PRP can be widely used in regenerative medicine owing to its tissue regeneration capability, which is likely to provide lucrative opportunities to the MENAT platelet rich plasma (PRP) tubes market in the coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

MENAT Platelet Rich Plasma (PRP) Tubes Market: Strategic Insights

MENAT Platelet Rich Plasma (PRP) Tubes Market

• Market Size 2021
  US$ 27.26 Million
• Market Size 2028
  US$ 79.71 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Regional Overview

• MENA

Market Segmentation

Usage

• Skin Rejuvenation
• Hair Restoration
• Orthopedics
• Surgical Oncology
• Gynecology

End User

• MedSpa
• Dermatology Office
• Hospitals and Healthcare Practice
• Tricologist

Volume

• Less Than 5 ml
• 6ml to 10 ml
• More Than 10 ml

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Usage-Based Insights

Based on usage, the MENAT platelet rich plasma (PRP) tubes market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynaecology, and others. The orthopedics segment held the largest share of the market in 2021. However, the skin rejuvenation segment is anticipated to register the highest CAGR of 17.3% in the market during the forecast period. The use of platelet-rich plasma (PRP) is expanding to numerous medical fields, including orthopedic surgery and sports medicine. In recent years, platelet rich plasma (PRP) has been widely used to treat orthopedic injuries-related diseases. It is most commonly used to treat orthopedic and sports injuries. PRP therapy is a form of regenerative medicine. Regenerative medicine centers on using the patient’s body tissue such as blood, fat, or bone marrow to heal the body. PRP has been used in operating rooms for several decades to help wound healing and stimulate bone formation in spinal fusion surgery. PRP has recently been used in outpatient settings to treat common overuse conditions, including achilles tendon, rotator cuff tendon, tennis elbow, patellar tendon, plantar fascia, hamstring tendon, and joint pain from arthritis or cartilage wear (particularly the knee).

MENAT Platelet Rich Plasma (PRP) Tubes Market, by Usage – 2021 and 2028

End User-Based Insights

Based on end user, the MENAT platelet rich plasma (PRP) tubes market is segmented medspa, dermatology office, hospitals, and healthcare practices, tricologist, and others. The hospitals and healthcare practices segment held the largest share of the market in 2021, and it is anticipated to register the highest CAGR of 16.4% in the market during the forecast period. Platelet transfusion was independently associated with ICU-acquired infection. Platelet (PLT) transfusion is used therapeutically in bleeding patients and is also recommended by guidelines to reduce the risk of bleeding in patients with thrombocytopenia (prophylactic transfusion). PRP therapy has been applied to an array of musculoskeletal injuries and has exhibited positive results in most of them.

Volume-Based Insights

Based on volume, the MENAT platelet rich plasma (PRP) tubes market is segmented into less than 5ml, 6ml to 10ml, and more than 10ml. The more than 10ml segment held the largest share of the market in 2021, and it is anticipated to register the highest CAGR of 16.3% in the market during the forecast period.

Companies are adopting various strategies, mainly product launches and approvals, to expand their footprints and product portfolios to dominate the platelet rich plasma (PRP) tubes market growth. Moreover, the market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name in MENAT region. The platelet rich plasma (PRP) tubes market growth is anticipated with the development of new innovative products by market players.

Company Profiles

• Manso Medical Co Ltd      
• Lingen Precision Medical Products Co Ltd             
• Integrity PRP        
• Henso Medical (Hangzhou) Co Ltd            
• Emerging Medical Group LLC        
• Juventix Regenerative Medical LLC           
• AdvaCare Pharma USA LLC

MENAT Platelet Rich Plasma (PRP) Tubes Market Report Scope